发明名称 Fused polycyclic 2-aminopyrimidine derivatives
摘要 Fused polycyclic 2-aminopyrimidines of formula (1) are described: wherein R1 is a group -L1 R2 where L1 is a covalent bond or a linker atom or group and R2 is a group -(Alk)mL2R3 where Alk is an optionally substituted aliphatic or heteroaliphatic chain, m is zero or the integer 1, L2 is a covalent bond or a linker atom or group and R3 is an optionally substituted cycloaliphatic or heterocycloaliphatic group provided that when m is zero L2 is a covalent bond; Ar is an aryl or heteroaryl group; X is a carbon or nitrogen atom; Y is a carbon or nitrogen atom; Z is a linker group; A together with X and Y forms an optionally substituted monocyclic or bicyclic aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are potent and selective inhibitors of protein kinases, especially src-family protein kinases and are of use in the prophylaxis and treatment of immune diseases, hyperproliferative disorders and other diseases in which inappropriate protein kinase action is believed to have a role.
申请公布号 US6133257(A) 申请公布日期 2000.10.17
申请号 US19980099171 申请日期 1998.06.18
申请人 CELLTECH THERAPEUTICS LIMITED 发明人 BATCHELOR, MARK JAMES;DAVIS, JEREMY MARTIN;MOFFAT, DAVID FESTUS CHARLES;DAVIS, PETER DAVID
分类号 A61K31/517;A61K31/5377;A61K31/551;A61P1/00;A61P9/00;A61P11/06;A61P17/06;A61P19/10;A61P25/00;A61P29/00;A61P35/00;A61P37/02;A61P37/06;A61P43/00;C07D239/70;C07D401/04;C07D401/12;C07D403/12;C07D405/04;C07D495/04;(IPC1-7):A61K31/517 主分类号 A61K31/517
代理机构 代理人
主权项
地址